🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

2,636 results for “-” Clear

  1. elosulfase alfa

    VIMIZIM BioMarin Pharmaceutical Australia Pty Ltd

    INJECTION FDA: approved · EMA: approved

    A16AB12

  2. eltrombopag choline

    ALVAIZ Teva Pharma GmbH

    ORAL FDA: approved

  3. eltrombopag olamine

    REVOLADE INITIAL APPROVAL Amneal Pharma Europe Ltd

    ORAL FDA: approved · PMDA: approved

  4. elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide

    ELVITEGRAVIR, COBICISTAT, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    FDA: approved

  5. elvitegravir/cobicistat/ emtricitabine/tenofovir alafenamide fumarate

    GENVOYA

    PMDA: approved

  6. elvitegravir/cobicistat/ emtricitabine/tenofovir disoproxil fumarate

    STRIBILD

    PMDA: approved

  7. emapalumab-lzsg

    GAMIFANT

    INJECTION FDA: approved

  8. emb-

    NMPA: clinical trials

  9. emedastine difumarate

    EMADINE

    OPHTHALMIC FDA: approved

  10. empagliflozin + linagliptin

    GLYXAMBI Boehringer Ingelheim Pty Ltd

    TGA: approved

  11. empagliflozin + metformin

    JARDIAMET 5 MG/500 MG Boehringer Ingelheim Pty Ltd

    TGA: approved

  12. empagliflozin, metformin hydrochloride

    EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

    FDA: approved

  13. emtricitabine + rilpivirine + tenofovir alafenamide

    ODEFSEY Gilead Sciences Pty Limited

    TGA: approved

  14. emtricitabine + tenofovir alafenamide

    DESCOVY Gilead Sciences Pty Limited

    TGA: approved

  15. emtricitabine, tenofovir alafenamide

    EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

    ORAL FDA: approved

  16. emulsifying ointment (for use only as a base combined with active ingredients)

    NULL

    TGA: approved

  17. emulsion-adjuvanted cell-culture derived influenza ha vaccine (prototype)

    EMULSION-ADJUVANTED CELL-CULTURE DERIVED INFLUENZA HA VACCINE (PROTOTYPE) FOR INTRAMUSCULAR INJECTION "KAKETSUKEN"

    PMDA: approved

  18. enalapril + hydrochlorothiazide

    RENITEC PLUS 20/6 Alphapharm Pty Ltd

    TGA: approved

  19. enalapril maleate

    AQUMELDI Amneal Pharma Europe Ltd

    ORAL FDA: approved · EMA: approved

    C09AA02

  20. enasidenib mesylate

    IDHIFA

    ORAL FDA: approved

  21. enfortumab vedotin

    PADCEV Astellas Pharma Inc

    EMA: approved · TGA: approved

    L01FX13

  22. enfortumab vedotin-ejfv

    PADCEV

    INJECTION FDA: approved

  23. enoxaparin sodium

    CLEXANE FORTE SAFETY-LOCK Sanofi-aventis Healthcare Pty Ltd

    INJECTION FDA: approved · EMA: approved · TGA: approved

    B01AB05

  24. ensartinib hydrochloride

    ENSACOVE

    ORAL FDA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources